| Position | General Manager |
|---|---|
| Speciality | Finance, Risk & Transformation |
| Qualifications & Professional Memberships |
|
| Areas of Expertise |
|
Ceryvyn Therapeutics Limited ABN 32 006 340 567.
An Australian biotechnology company (ASX: CYV) developing a biologic therapy for the rare disease LAM
(lymphangioleiomyomatosis).
Subscribe to Updates
© 2026 Ceryvyn Therapeutics All rights reserved